Gentian Diagnostics ASA reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was NOK 38.5 million compared to NOK 31.44 million a year ago. Net income was NOK 4.16 million compared to net loss of NOK 0.657 million a year ago.

Basic earnings per share from continuing operations was NOK 0.27 compared to basic loss per share from continuing operations of NOK 0.04 a year ago. Diluted earnings per share from continuing operations was NOK 0.27 compared to diluted loss per share from continuing operations of NOK 0.04 a year ago.